Axsome Therapeutics Cash from Financing (TTM) Insights

Axsome Therapeutics Inc (AXSM)

74.85 +1.13 (+1.53%) USD | NASDAQ | May 01, 16:00

74.85 0.00 (0.00%) After-Hours: 16:03

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	331.01M
September 30, 2023	332.08M
June 30, 2023	475.66M
March 31, 2023	305.04M
December 31, 2022	284.58M
September 30, 2022	284.21M
June 30, 2022	107.70M
March 31, 2022	34.20M
December 31, 2021	11.13M
September 30, 2021	12.53M
June 30, 2021	39.52M
March 31, 2021	49.81M
December 31, 2020	42.41M
September 30, 2020	234.22M
June 30, 2020	207.31M
March 31, 2020	214.86M
December 31, 2019	252.39M

Date	Value
September 30, 2019	67.04M
June 30, 2019	67.31M
March 31, 2019	48.88M
December 31, 2018	10.03M
September 30, 2018	10.13M
June 30, 2018	9.471M
March 31, 2018	8.150M
December 31, 2017	23.88M
September 30, 2017	25.20M
June 30, 2017	25.08M
March 31, 2017	25.01M
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	52.88M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

11.13M

Minimum

Dec 2021

475.66M

Maximum

Jun 2023

176.47M

Average

207.31M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks